Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1998
11/26/1998WO1998052943A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998WO1998052942A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998WO1998052935A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/26/1998WO1998052898A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998WO1998052593A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998WO1998052577A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998WO1998052574A1 Vitamin d analogues and their neuronal effects
11/26/1998WO1998052565A1 Substance dependence treatment using opiate antagonists and serotonin compounds
11/26/1998WO1998052560A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052548A2 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
11/26/1998WO1998022494A3 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
11/26/1998DE19739332C1 New 5-Ý4-(4-fluorobenzyl)-piperidin-1-yl¨-3(4-hydroxyphenyl)-oxazolidine-2-one
11/26/1998DE19721580A1 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension states
11/26/1998CA2291111A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998CA2290818A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998CA2290788A1 Substance dependence treatment using opiate antagonists and serotonin compounds
11/26/1998CA2290778A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998CA2290772A1 Vitamin d analogues and their neuronal effects
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2290598A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998CA2290556A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998CA2290475A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998CA2290381A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639)
11/25/1998EP0879596A2 Use of cholinesterase inhibitors to reduce benzodiazepine side effects
11/25/1998EP0879234A1 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system
11/25/1998EP0879230A2 Optically active phenyl pyrimidine derivative as analgesic agent
11/25/1998EP0879054A1 Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
11/25/1998EP0711291B1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists
11/25/1998EP0652866B1 Azacyclic compounds
11/25/1998CN1200127A Novel opioid peptides
11/25/1998CN1200121A Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds
11/25/1998CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998CN1200119A (Methylsulfonyl) phenyl-2-(5H)-furanones as cox-2 inhibitors
11/25/1998CN1200115A Chiral methyl phenyl oxazolidinones
11/24/1998US5840979 Useful in the treatment and prevention of diseases in which cell death occurs by apoptosis
11/24/1998US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998US5840906 Forming anabaseine using nicotinyl piperidone salt
11/24/1998US5840903 5-ht3 and 5-ht4 agonists and antagonists
11/24/1998US5840842 Receptor-type phosphotyrosine phosphatase-sigma
11/24/1998US5840756 Pharmaceutical composition of L-DOPA ester
11/24/1998US5840736 Methods and compositions for stimulating neurite growth
11/24/1998US5840731 Pain-alleviating drug composition and method for alleviating pain
11/24/1998US5840729 Attenuating cognitive deficit
11/24/1998US5840727 (4-heteroaryl)-1- (2,3-dihydro-1H-isoindol-2-yl) alkyl! piperazines and related compounds and their therapeutic utility
11/24/1998US5840725 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/24/1998US5840722 Administering to inhibit endothelin receptors
11/24/1998US5840719 Apoptosis inhibitors for treating neurodegenerative diseases
11/24/1998US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto
11/24/1998US5840708 Administering antisense oligonucleotide which hybridizes to expression controlling sequence of nucleic acid encoding dopamine receptor to inhibit production
11/24/1998US5840682 Peptide antagonists of neurotensin
11/24/1998US5840540 Sequence determination and expression of familial alzheimer's disease membrane protein
11/24/1998US5840491 DNA sequence encoding the Machado-Joseph disease gene and uses thereof
11/24/1998US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate
11/24/1998US5840307 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998US5840294 Method for treating amyloidosis
11/24/1998CA2159591C Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
11/24/1998CA2155130C Xanthine derivatives as adenosine a1 receptor antagonists
11/24/1998CA2007181C Sustained release pharmaceutical composition
11/23/1998CA2232810A1 Novel compounds
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2232807A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/23/1998CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639)
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/19/1998WO1998051671A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/19/1998WO1998051668A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051655A1 Excitatory amino acid receptor modulators
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998051310A1 A method for the treatment of mental illness in mammals and a composition therefor
11/19/1998WO1998051302A1 Composition and methods for treating alzheimer's disease and other amyloidoses
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998WO1998026062A3 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2288850A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0878463A1 Excitatory amino acid receptor modulators
11/18/1998EP0878199A1 Natural teas for taking off the effects of drink and process for the production thereof
11/18/1998EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto
11/18/1998EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS
11/18/1998EP0877760A1 Mhc complexes and uses thereof
11/18/1998EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor
11/18/1998EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998EP0877747A1 Azaspiro derivatives with 5ht 1b? activity
11/18/1998EP0877744A1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
11/18/1998EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998EP0877735A1 Polycyclic compounds
11/18/1998EP0877612A1 Use of piperazine derivatives for the treatment of cognitive disorders
11/18/1998EP0877609A1 Formulation for respiratory tract administration
1 ... 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 ... 1833